Berlin - Delayed Quote EUR
Cardinal Health Inc (CLH.BE)
123.15
+2.55
+(2.11%)
At close: 9:48:27 PM GMT+2
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
222,276,000
226,827,000
204,979,000
181,326,000
162,467,000
Cost of Revenue
214,616,000
219,413,000
198,105,000
174,842,000
155,689,000
Gross Profit
7,660,000
7,414,000
6,874,000
6,484,000
6,778,000
Operating Expense
5,465,000
5,284,000
5,085,000
4,836,000
4,984,000
Operating Income
2,195,000
2,130,000
1,789,000
1,648,000
1,794,000
Net Non Operating Interest Income Expense
-104,000
-51,000
-84,000
-147,000
-180,000
Other Income Expense
-306,000
-878,000
-1,042,000
-2,285,000
-1,291,000
Pretax Income
1,785,000
1,201,000
663,000
-784,000
323,000
Tax Provision
472,000
348,000
332,000
153,000
-289,000
Net Income Common Stockholders
1,312,000
852,000
330,000
-938,000
611,000
Diluted NI Available to Com Stockholders
1,312,000
852,000
330,000
-938,000
611,000
Basic EPS
5.41
3.48
1.00
-3.35
2.09
Diluted EPS
5.37
3.45
1.00
-3.35
2.08
Basic Average Shares
242,500
245,000
261,000
279,000
292,000
Diluted Average Shares
244,500
247,000
262,000
279,000
294,000
Total Operating Income as Reported
1,887,000
1,243,000
752,000
-607,000
472,000
Total Expenses
220,081,000
224,697,000
203,190,000
179,678,000
160,673,000
Net Income from Continuing & Discontinued Operation
1,312,000
852,000
330,000
-938,000
611,000
Normalized Income
1,538,556.86
1,482,657
1,149,230
849,770
1,587,740
Interest Expense
104,000
51,000
84,000
147,000
180,000
Net Interest Income
-104,000
-51,000
-84,000
-147,000
-180,000
EBIT
1,889,000
1,252,000
747,000
-637,000
503,000
EBITDA
2,626,000
1,962,000
1,439,000
55,000
1,286,000
Reconciled Cost of Revenue
214,215,000
218,987,000
197,698,000
174,474,000
155,357,000
Reconciled Depreciation
737,000
710,000
692,000
692,000
783,000
Net Income from Continuing Operation Net Minority Interest
1,312,000
852,000
330,000
-938,000
611,000
Total Unusual Items Excluding Goodwill
-308,000
-887,000
-1,037,000
-2,263,000
-1,338,000
Total Unusual Items
-308,000
-887,000
-1,037,000
-2,263,000
-1,338,000
Normalized EBITDA
2,934,000
2,849,000
2,476,000
2,318,000
2,624,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-81,443.14
-256,343
-217,770
-475,230
-361,260
6/30/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade